packageNiraparib

niraparib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Niraparib is a PARP inhibitor anticancer medicine used to treat ovarian, fallopian tube, and peritoneal cancers. It is authorised in the European Union and is an approved drug, used in cancer care.

Summary written by glm-5.3-flash from Wikidata Q25326660 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:niraparib
ATC codes:L01XK02
DrugBank:DB11793
PubChem CID:24958200
ChEBI:176844
Wikidata:Q25326660
formula:C19H20N4O
molar mass:320.396 g/mol (PubChem CID 24958200)
logP:2.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown